Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
197
-
Shares change
-
+97
-
Total reported value, excl. options
-
$2K
-
Value change
-
+$1K
-
Put/Call ratio
-
0.29
-
Number of buys
-
1
-
Price
-
$5.69
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q2 2015
5 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q2 2015.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 197 shares
of 41M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (100 shares), Citadel Advisors LLC (97 shares), Jefferies Group LLC (35K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (33K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (19.5K shares), SABBY MANAGEMENT, LLC (212K shares), GREYLIN INVESTMENT MANGEMENT INC (45.1K shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (40K shares), HSBC HOLDINGS PLC (15K shares), and WELLS FARGO & COMPANY/MN (6.5K shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.